Dr. Herbst on MPDL3280A for Non-Small Cell Lung Cancer
1 Views
administrator
07/14/23
Roy S. Herbst, MD, PhD, a professor of Medicine at Yale Cancer Center and chief of Medical Oncology at Smilow Cancer Hospital at Yale-New Haven in Connecticut, comments on the emergence of immunotherapies for multiple types of cancer including MPDL3280A for non-small cell lung cancer.
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
-
Category
Show more
Facebook Comments
No comments found